You just read:

Genomic Health Announces Multiple Studies Reinforcing Value of Oncotype DX® Tests in Guiding Treatment for Breast and Prostate Cancer Patients

News provided by

Genomic Health, Inc.

Oct 22, 2018, 08:00 ET